SGLT2 Inhibitor.
Sodium-glucose cotransporter 2 inhibitor. Originally developed for diabetes, these medications (empagliflozin, dapagliflozin) have shown significant benefits in heart failure, reducing hospitalizations and cardiovascular death regardless of diabetes status.
Definition
What is sglt2 inhibitor?
Sodium-glucose cotransporter 2 inhibitor. Originally developed for diabetes, these medications (empagliflozin, dapagliflozin) have shown significant benefits in heart failure, reducing hospitalizations and cardiovascular death regardless of diabetes status.
Related Terms
Related glossary terms.
Stay informed.
Expert cardiac surgery insights from the WhiteGloveMD Heart Team, delivered to your inbox.
No spam. Unsubscribe anytime. HIPAA-compliant.
Have questions about sglt2 inhibitor?
Our Heart Team provides expert second opinions with plain-language explanations. 24-hour turnaround.